AT

Atlas Venture

VC
Cambridge, MAWebsite
How to approach: warm intro preferred
Stage

Seed, Series A

Check Size

$500K – $12.0M

AUM

$2.7B

Portfolio

6+ companies

Team

11 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Atlas is dedicated to early-stage biotech innovations, particularly in oncology and advanced therapeutics.

Meet the Team

JF

Jean-Francois Formela

Partner

BB

Bruce Booth

Partner

Biotech
Oncology
Cell Therapy
MG

Michael Gladstone

Partner

KB

Kevin Bitterman

Partner

PB

Peter Barrett

Partner

KM

Kristen Margeson

Vice President

ES

Eric Schmid

Vice President of Legal Affairs

LA

Laura Alessio

Director of Operations

DK

Doug Kerr

Venture Partner

CM

Carlos Moreno

General Partner

AI/ML
Enterprise SaaS
OC

Ommer Chohan

Chief Financial Officer

Industry Focus

Invests In

Healthcare
Other

Portfolio Companies (6)

Other

KY

Kymera Therapeutics

Oncology
RE

Repertoire Immune Medicines

Immunotherapy
ST

StreamlineAI

AI SaaS
FL

FlowOps

B2B SaaS
PR

Pride Fund, LLC (CIK 0001811278)

"Discovered via sec_edgar_form_d (high confidence)"

SEC Form D filing mentioning Atlas Venture

UN

United Dream Fund I, L.P. (CIK 0001878289)

"Discovered via sec_edgar_form_d (high confidence)"

SEC Form D filing mentioning Atlas Venture

Browse More Investors

Frequently Asked Questions

See if Atlas Venture is a match for your startup

Upload your pitch deck to see how well you match with Atlas Venture and 200+ other VC firms.